Yeo EJ - Search Results

1

A new HIF-1 alpha variant induced by zinc ion suppresses HIF-1-mediated hypoxic responses.

Chun YS, Choi E, Yeo EJ, Lee JH, Kim MS, Park JW. Chun YS, et al. Among authors: yeo ej. J Cell Sci. 2001 Nov;114(Pt 22):4051-61. doi: 10.1242/jcs.114.22.4051. J Cell Sci. 2001. PMID: 11739637

2

New anticancer strategies targeting HIF-1.

Yeo EJ, Chun YS, Park JW. Yeo EJ, et al. Biochem Pharmacol. 2004 Sep 15;68(6):1061-9. doi: 10.1016/j.bcp.2004.02.040. Biochem Pharmacol. 2004. PMID: 15313402 Review.

3

A domain responsible for HIF-1alpha degradation by YC-1, a novel anticancer agent.

Kim HL, Yeo EJ, Chun YS, Park JW. Kim HL, et al. Among authors: yeo ej. Int J Oncol. 2006 Jul;29(1):255-60. Int J Oncol. 2006. PMID: 16773207

4

FK506: an immunosuppressive agent preserving HIF-1 activity.

Kim KE, Jung YJ, Yeo EJ, Chun YS, Park JW. Kim KE, et al. Among authors: yeo ej. Immunopharmacol Immunotoxicol. 2006;28(4):609-20. doi: 10.1080/08923970601067094. Immunopharmacol Immunotoxicol. 2006. PMID: 17190738

5

Contribution of HIF-1alpha or HIF-2alpha to erythropoietin expression: in vivo evidence based on chromatin immunoprecipitation.

Yeo EJ, Cho YS, Kim MS, Park JW. Yeo EJ, et al. Ann Hematol. 2008 Jan;87(1):11-7. doi: 10.1007/s00277-007-0359-6. Epub 2007 Aug 22. Ann Hematol. 2008. PMID: 17712557

6

Inhibitory effect of YC-1 on the hypoxic induction of erythropoietin and vascular endothelial growth factor in Hep3B cells.

Chun YS, Yeo EJ, Choi E, Teng CM, Bae JM, Kim MS, Park JW. Chun YS, et al. Among authors: yeo ej. Biochem Pharmacol. 2001 Apr 15;61(8):947-54. doi: 10.1016/s0006-2952(01)00564-0. Biochem Pharmacol. 2001. PMID: 11286986

7

YC-1: a potential anticancer drug targeting hypoxia-inducible factor 1.

Yeo EJ, Chun YS, Cho YS, Kim J, Lee JC, Kim MS, Park JW. Yeo EJ, et al. J Natl Cancer Inst. 2003 Apr 2;95(7):516-25. doi: 10.1093/jnci/95.7.516. J Natl Cancer Inst. 2003. PMID: 12671019

8

Phorbol ester stimulates the nonhypoxic induction of a novel hypoxia-inducible factor 1alpha isoform: implications for tumor promotion.

Chun YS, Lee KH, Choi E, Bae SY, Yeo EJ, Huang LE, Kim MS, Park JW. Chun YS, et al. Among authors: yeo ej. Cancer Res. 2003 Dec 15;63(24):8700-7. Cancer Res. 2003. PMID: 14695184

9

Versatile pharmacological actions of YC-1: anti-platelet to anticancer.

Chun YS, Yeo EJ, Park JW. Chun YS, et al. Among authors: yeo ej. Cancer Lett. 2004 Apr 15;207(1):1-7. doi: 10.1016/j.canlet.2004.01.005. Cancer Lett. 2004. PMID: 15127725 Review.

10

Amphotericin B blunts erythropoietin response to hypoxia by reinforcing FIH-mediated repression of HIF-1.

Yeo EJ, Ryu JH, Cho YS, Chun YS, Huang LE, Kim MS, Park JW. Yeo EJ, et al. Blood. 2006 Feb 1;107(3):916-23. doi: 10.1182/blood-2005-06-2564. Epub 2005 Sep 27. Blood. 2006. PMID: 16189267 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

137 results

Search Page

Filters